| Compound | Botulinum Toxin |
|---|---|
| Category | Neurotoxin (regulated biologic) |
| Class | Other Injectables |
| Evidence tier | Approved medicine |
| WADA status | Not individually listed; verify current status if subject to testing |
| Sold on this site | No — this is a reference database |
Overview
Botulinum Toxin — a neurotoxin (regulated biologic) — sits in the "Approved medicine" tier of this catalog. This compound exists as an approved medicine in at least one major jurisdiction. Approval applies to specific, labeled indications and to the regulated product — not to compounded or research-grade copies.
A regulated biologic medicine produced from Clostridium botulinum, approved for a long list of cosmetic and therapeutic indications from frown lines to spasticity and migraine.
Mechanism of Action
The toxin’s light chain cleaves SNARE proteins, blocking acetylcholine release at neuromuscular junctions and producing localized chemodenervation.
Research and Evidence
Multiple products (Botox, Dysport, Xeomin, others) carry registrational evidence across approved indications.
Safety and Side Effects
Potentially lethal in uncontrolled form; approved products are dosed in units with strict handling requirements. Unregulated "cosmetic toxin" is a documented counterfeit hazard.
Frequently Asked Questions
What is the evidence tier of Botulinum Toxin?
Botulinum Toxin is graded "Approved medicine" on this site. This compound exists as an approved medicine in at least one major jurisdiction. Approval applies to specific, labeled indications and to the regulated product — not to compounded or research-grade copies.
Is Botulinum Toxin an approved medicine?
Botulinum Toxin exists as an approved medicine in at least one major jurisdiction — but approval covers the regulated product and its labeled indications only. Compounded or research-grade versions of the same molecule are not the approved product.
Where can I read the primary studies for Botulinum Toxin?
The references section at the end of this entry links the key primary sources — regulator labels, trial registrations, and peer-reviewed papers. Our "How to Read a Peptide Study" guide explains how to evaluate them.
References
- ClinicalTrials.gov — registered botulinum toxin studies. [source]
Evidence tier: Approved medicine · Last reviewed: 2026-09-05 · Sources cited below.